Every 10-Q that Mobix Labs, Inc. (MOBX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MOBX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MOBX filings page.
Mobix Labs, Inc. reported sharply weaker results for the nine months ended June 30, 2026. Total net revenue was $3.63 million, down from $8.03 million a year earlier, with quarterly revenue for the June 2026 quarter falling to $0.79 million from $2.35 million. Gross profit for the nine-month period declined to $0.87 million from $4.06 million.
The company recorded a net loss of $32.77 million for the nine months, compared with a $30.40 million loss in the prior-year period, and used $14.72 million of cash in operating activities. Cash on hand was only $2.14 million as of June 30, 2026, with an accumulated deficit of $183.36 million. Management states there is substantial doubt about the company’s ability to continue as a going concern without additional financing.
To fund operations, Mobix raised capital through equity and complex financings, including a $4.00 million Leviston senior secured convertible note (later converted into 2.5 million shares), additional Leviston convertible notes measured at fair value, and the issuance of 2,000 shares of Series A 10% Convertible Preferred Stock with a $1,200 per-share stated value and associated warrants. These instruments, along with prior debt and payable settlements in shares, create meaningful potential dilution relative to the 15.0 million Class A and 200,491 Class B shares outstanding.
Mobix Labs, Inc. reported sharply lower revenue and continued losses for the quarter ended March 31, 2026 while warning of substantial doubt about its ability to continue as a going concern. Quarterly net revenue was $970, down from $2,511 a year earlier, with a net loss of $5,853 compared with $2,291 in the prior-year period.
For the first six months of fiscal 2026, net revenue totaled $2,845 and the net loss was $15,978. Cash stood at $2,563 against total debt of $6,438, and net cash used in operations reached $9,017. The company improved its capital structure from a small equity deficit to positive stockholders’ equity of $8,845 through public equity offerings, ATM sales and exchanges of debt and payables into shares, but these transactions were dilutive to existing holders.
Management states that ongoing operating losses, negative operating cash flows and limited liquidity mean additional debt or equity financing is required to meet obligations over the next twelve months. Subsequent events include a 1‑for‑10 reverse stock split, full conversion of a $4,000 senior secured convertible note into 2,500,000 shares, and a new $2,400 Series A 10% Convertible Preferred Stock financing with attached purchase warrant, further emphasizing reliance on capital markets.
Mobix Labs, Inc. reported a net loss of $10.1 million for the three months ended December 31, 2025, narrower than the $19.8 million loss a year earlier. Revenue fell to $1.9 million from $3.2 million, with both product and services sales declining.
Gross profit dropped to $0.6 million, and interest expense increased to $1.4 million as total debt reached $6.3 million. Despite lower operating expenses, especially stock-based compensation, the company ended the quarter with only $0.3 million in cash, prompting a going concern warning about its ability to meet obligations over the next year.
Stockholders’ equity improved to $4.7 million from a deficit at September 30, 2025, helped by share issuances and warrant reclassification. After quarter-end, Mobix raised approximately $5.1 million net through a public offering of 30 million Class A shares at $0.20 each and issued additional make-whole shares to a lender.